MARCHESE, GIORGIO
 Distribuzione geografica
Continente #
EU - Europa 19.948
NA - Nord America 1.826
AS - Asia 204
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 21.982
Nazione #
IT - Italia 19.526
US - Stati Uniti d'America 1.821
UA - Ucraina 168
CN - Cina 162
SE - Svezia 117
FI - Finlandia 47
DE - Germania 41
SG - Singapore 34
GB - Regno Unito 32
FR - Francia 12
IN - India 7
CA - Canada 5
BE - Belgio 2
CL - Cile 2
EU - Europa 2
CZ - Repubblica Ceca 1
IR - Iran 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 21.982
Città #
Cagliari 19.268
Fairfield 261
Woodbridge 243
Uta 201
Chandler 158
Houston 148
Ashburn 117
Ann Arbor 115
Seattle 100
Nyköping 94
Jacksonville 91
Wilmington 90
Cambridge 87
Boardman 85
Dearborn 61
Shanghai 39
Nanjing 28
Santa Clara 27
Boston 25
Helsinki 20
San Diego 16
Singapore 16
Beijing 12
Shenyang 10
Changsha 9
Milan 9
Hebei 8
Tianjin 8
Jinan 7
Norwalk 7
Jiaxing 6
Frankfurt am Main 5
New York 5
Ningbo 5
Orange 5
London 4
Toronto 4
Verona 4
Washington 4
Auburn Hills 3
Hefei 3
Kunming 3
Zhengzhou 3
Borås 2
Brussels 2
Fuzhou 2
Guangzhou 2
Hangzhou 2
Los Angeles 2
Nanchang 2
Rome 2
Wuhan 2
Ardabil 1
Augusta 1
Bilston 1
Brno 1
Chengdu 1
Dallas 1
Frechen 1
Lanzhou 1
Las Vegas 1
Leawood 1
Madison 1
Mountain View 1
Mumbai 1
New Bedfont 1
Ottawa 1
Paris 1
Prescot 1
Pune 1
Redmond 1
Redwood City 1
Rockville 1
Saint Petersburg 1
San Mateo 1
Stockholm 1
Wenzhou 1
Yiwu 1
Totale 21.458
Nome #
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.674
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor 1.578
The cerebellar GABAA alpha6 subunit is differentially modulated by chronic ethanol exposure in normal (R100R) and mutated (Q100Q) sNP rats 1.496
Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration. Eur J Pharmacol. 2008 Nov 19;598(1-3):16-20 1.298
Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications 1.112
Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays. 995
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract 893
null 886
In vitro evidence for the presence of [3H]-haloperidol uptake in rat brain 860
Effects of controlled-release formulations of atypical antipsychotics on functioning and quality of life of schizophrenic individuals. 794
Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol 786
Effect of the amisulpride isomers on rat catalepsy 741
Imbalance towards inhibition as a substrate of aging-associated cognitive impairment 739
Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats 708
Haloperidol versus risperidone on rat "early onset" vacuous chewing 660
Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice 657
Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release 639
The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex 633
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect 626
Effect of the amisulpride isomers on rat prolactinemia 607
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing 582
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats 575
Antipsychotic efficacy: relationship to optimal D2-receptor occupancy 551
Antinociceptive activity of Delta(9)-tetrahydrocannabinol non-ionic microemulsions 519
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid 443
Different affinity of cortical GHB binding sites in sardinian alcohol-preferring (sP) and -non preferring (sNP) rats 435
Loss of presynaptic and postsynaptic structures is accompanied by compensatory increase in action potential-dependent synaptic input to layer V neocortical pyramidal neurons in aged rats 380
Molecular characterization of new polymorphisms at the beta2, alpha1, gamma2 GABA(A) receptor subunit genes associated to a rat nonpreferring ethanol phenotype 140
Totale 22.007
Categoria #
all - tutte 28.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.435 0 0 0 0 2.525 1.477 849 159 84 65 125 151
2020/20217.172 185 230 262 2.723 1.818 620 460 396 47 194 142 95
2021/20221.348 86 88 36 66 187 174 57 22 97 127 214 194
2022/20231.502 139 175 185 138 126 149 58 210 92 81 57 92
2023/20241.242 96 73 92 110 132 157 143 103 44 79 84 129
2024/2025592 83 75 240 79 115 0 0 0 0 0 0 0
Totale 22.007